483
University of Miami Infertility CenterUniversity of Miami Infertility Center – FDA 483, Jun 13, 2019
Record Details
The University of Miami Reproductive and Fertility Center received an FDA Form 483 for failing to establish and maintain procedures for donor eligibility screening of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). This included specific deficiencies in screening for ZIKV, West Nile Virus NAT, and HBV NAT. This is a repeat deficiency, indicating a persistent issue.
View Company Profile
ID · 6fc7b1d9-69c4-461a-b82e-6ec6b9b656ec
Other documents for University of Miami Infertility Center
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.